Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients
Leukapheresis Procedures to Obtain Lymphocytes for Research Studies on Antiretroviral Naive HIV-infected Patients
Sponsor: Canadian Immunodeficiency Research Collaborative
A observational or N/A phase clinical study on Human Immunodeficiency Virus, this trial is completed. The trial is conducted by Canadian Immunodeficiency Research Collaborative and has accumulated 10 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: PHASE2 → None
-
Aug 2017 — Apr 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Completed PHASE2
First recorded
Aug 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Immunodeficiency Research Collaborative
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.